| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| Delaware | 88-0706021 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
| 950 Winter Street 4th Floor North | Waltham | MA | 02451 | ||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
| Common Stock, par value $1.00 | CXT | New York Stock Exchange | ||||||
| Page | ||||||||
| Part I - Financial Information | ||||||||
Page 3 | ||||||||
Page 4 | ||||||||
Page 5 | ||||||||
Page 7 | ||||||||
Page 9 | ||||||||
Page 10 | ||||||||
Page 23 | ||||||||
Page 29 | ||||||||
Page 29 | ||||||||
| Part II - Other Information | ||||||||
Page 30 | ||||||||
Page 30 | ||||||||
Page 30 | ||||||||
Page 30 | ||||||||
Page 30 | ||||||||
Page 30 | ||||||||
Page 31 | ||||||||
Page 32 | ||||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| (in millions, except per share data) | 2026 | 2025 | ||||||||||||
| Net sales | $ | 387.7 | $ | 330.3 | ||||||||||
| Operating costs and expenses: | ||||||||||||||
| Cost of sales | 231.8 | 190.1 | ||||||||||||
| Selling, general and administrative | 130.6 | 102.9 | ||||||||||||
| Restructuring charges | 3.1 | — | ||||||||||||
| Operating profit | 22.2 | 37.3 | ||||||||||||
| Other (expense) income: | ||||||||||||||
| Interest expense | (17.8) | (11.5) | ||||||||||||
| Equity investment income | 4.7 | 0.1 | ||||||||||||
| Miscellaneous income, net | 0.1 | 2.2 | ||||||||||||
| Total other expense, net | (13.0) | (9.2) | ||||||||||||
| Income before income taxes | 9.2 | 28.1 | ||||||||||||
| Provision for income taxes | 2.4 | 6.4 | ||||||||||||
| Net income before allocation to noncontrolling interest | 6.8 | 21.7 | ||||||||||||
| Less: Noncontrolling interest in subsidiaries’ earnings | 0.4 | — | ||||||||||||
| Net income attributable to common shareholders | $ | 6.4 | $ | 21.7 | ||||||||||
| Earnings per share: | ||||||||||||||
| Basic | $ | 0.11 | $ | 0.38 | ||||||||||
| Diluted | $ | 0.11 | $ | 0.38 | ||||||||||
| Average shares outstanding: | ||||||||||||||
| Basic | 57.5 | 57.3 | ||||||||||||
| Diluted | 58.0 | 57.9 | ||||||||||||
| Dividends per share | $ | 0.18 | $ | 0.17 | ||||||||||
| Three Months Ended | |||||||||||||||||
| March 31, | |||||||||||||||||
| (in millions) | 2026 | 2025 | |||||||||||||||
| Net income before allocation to noncontrolling interest | $ | 6.8 | $ | 21.7 | |||||||||||||
| Components of other comprehensive (loss) income, net of tax | |||||||||||||||||
| Currency translation adjustment | (10.8) | 31.1 | |||||||||||||||
| Changes in pension and postretirement plan assets and benefit obligation, net of tax | (0.2) | (0.2) | |||||||||||||||
| Other comprehensive (loss) income, net of tax | (11.0) | 30.9 | |||||||||||||||
| Comprehensive (loss) income before allocation to noncontrolling interest | $ | (4.2) | $ | 52.6 | |||||||||||||
| Less: Noncontrolling interest in comprehensive income | 0.4 | — | |||||||||||||||
| Comprehensive (loss) income attributable to common shareholders | $ | (4.6) | $ | 52.6 | |||||||||||||
| (in millions) | March 31, 2026 | December 31, 2025 | |||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 228.3 | $ | 233.8 | |||||||
Accounts receivable, net of allowance for credit losses of $9.5 as of March 31, 2026 and $8.9 as of December 31, 2025 | 420.0 | 351.8 | |||||||||
| U.S. and foreign taxes on income | 14.1 | 12.7 | |||||||||
| Inventories, net: | |||||||||||
| Finished goods | 77.1 | 26.6 | |||||||||
| Finished parts and subassemblies | 32.6 | 23.8 | |||||||||
| Work in process | 34.1 | 29.4 | |||||||||
| Raw materials | 116.7 | 89.7 | |||||||||
| Inventories, net | 260.5 | 169.5 | |||||||||
| Other current assets | 91.2 | 85.1 | |||||||||
| Total current assets | 1,014.1 | 852.9 | |||||||||
| Property, plant and equipment: | |||||||||||
| Cost | 716.3 | 688.9 | |||||||||
| Less: accumulated depreciation | 395.1 | 385.1 | |||||||||
| Property, plant and equipment, net | 321.2 | 303.8 | |||||||||
| Long-term deferred tax assets | 11.6 | 2.5 | |||||||||
| Investment in equity affiliates and joint ventures | 8.1 | 139.4 | |||||||||
| Intangible assets, net | 789.3 | 557.2 | |||||||||
| Goodwill | 1,398.2 | 1,164.0 | |||||||||
| Other assets | 97.9 | 96.6 | |||||||||
| Total assets | $ | 3,640.4 | $ | 3,116.4 | |||||||
| (in millions, except per share and share data) | March 31, 2026 | December 31, 2025 | |||||||||
| Liabilities and equity | |||||||||||
| Current liabilities: | |||||||||||
| Short-term borrowings | $ | 249.5 | $ | 135.1 | |||||||
| Accounts payable | 130.8 | 132.3 | |||||||||
| Accrued liabilities | 358.1 | 273.0 | |||||||||
| U.S. and foreign taxes on income | 24.3 | 28.7 | |||||||||
| Total current liabilities | 762.7 | 569.1 | |||||||||
| Long-term debt | 1,259.4 | 1,004.4 | |||||||||
| Accrued pension and postretirement benefits | 27.8 | 19.1 | |||||||||
| Long-term deferred tax liability | 212.3 | 151.0 | |||||||||
| Other liabilities | 119.6 | 116.0 | |||||||||
| Total liabilities | 2,381.8 | 1,859.6 | |||||||||
| Commitments and contingencies (Note 11) | |||||||||||
| Redeemable noncontrolling Interests | 21.1 | 6.9 | |||||||||
| Equity: | |||||||||||
Preferred shares, par value $0.01; 5,000,000 shares authorized | — | — | |||||||||
Common shares, par value $1.00; 200,000,000 shares authorized | 72.4 | 72.4 | |||||||||
| Capital surplus | 1,709.3 | 1,716.5 | |||||||||
| Retained earnings | 370.6 | 374.5 | |||||||||
| Accumulated other comprehensive loss | (110.9) | (99.9) | |||||||||
| Treasury stock | (802.3) | (810.5) | |||||||||
| Total shareholders’ equity | 1,239.1 | 1,253.0 | |||||||||
| Nonredeemable noncontrolling interests | (1.6) | (3.1) | |||||||||
| Total equity | 1,237.5 | 1,249.9 | |||||||||
| Total liabilities, redeemable noncontrolling interests, and equity | $ | 3,640.4 | $ | 3,116.4 | |||||||
| Share data: | |||||||||||
| Common shares issued | 72,441,647 | 72,441,647 | |||||||||
| Less: Common shares held in treasury | 14,904,359 | 15,000,106 | |||||||||
| Common shares outstanding | 57,537,288 | 57,441,541 | |||||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| (in millions) | 2026 | 2025 | |||||||||
| Operating activities: | |||||||||||
| Net income before allocation to noncontrolling interest | $ | 6.8 | $ | 21.7 | |||||||
| Adjustments to reconcile net income to net cash flows used for operating activities: | |||||||||||
| Depreciation and amortization | 29.7 | 21.6 | |||||||||
Stock-based compensation expense1 | 14.8 | 2.9 | |||||||||
| Income from equity investments | (4.7) | (0.1) | |||||||||
| Deferred income taxes | (1.9) | (0.5) | |||||||||
| Cash used for operating working capital | (51.3) | (61.4) | |||||||||
| Other | (7.4) | (3.3) | |||||||||
| Total used for operating activities | (14.0) | (19.1) | |||||||||
| Investing activities: | |||||||||||
| Proceeds from disposition of assets | 4.6 | — | |||||||||
| Payment for acquisitions, net of cash acquired | (225.4) | — | |||||||||
| Capital expenditures | (10.1) | (13.1) | |||||||||
| Settlement of forward contracts | (0.3) | (0.5) | |||||||||
| Total used for investing activities | (231.2) | (13.6) | |||||||||
| Financing activities: | |||||||||||
| Dividends paid | (10.3) | (9.7) | |||||||||
| Proceeds from stock options exercised | — | 0.6 | |||||||||
| Payment of tax withholding on equity awards vested | (2.8) | (5.6) | |||||||||
| Debt issuance costs | (1.6) | (0.8) | |||||||||
| Proceeds from revolving credit facility | 30.0 | 106.0 | |||||||||
| Repayments of revolving credit facility | (30.0) | (52.5) | |||||||||
| Proceeds from term loan | 366.9 | — | |||||||||
| Repayment of term loan | (112.4) | — | |||||||||
| Total provided by financing activities | 239.8 | 38.0 | |||||||||
| Effect of exchange rates on cash, cash equivalents and restricted cash | (1.8) | 6.7 | |||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash | (7.2) | 12.0 | |||||||||
Cash, cash equivalents and restricted cash at beginning of period2 | 246.2 | 173.4 | |||||||||
Cash, cash equivalents and restricted cash at end of period3 | $ | 239.0 | $ | 185.4 | |||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| (in millions) | 2026 | 2025 | |||||||||
| Detail of cash used for operating working capital: | |||||||||||
| Accounts receivable | $ | (9.0) | $ | 1.5 | |||||||
| Inventories | (23.2) | (9.8) | |||||||||
| Other current assets | (5.1) | (5.0) | |||||||||
| Accounts payable | (26.8) | (27.3) | |||||||||
| Accrued liabilities | 19.9 | (11.5) | |||||||||
| U.S. and foreign taxes on income | (7.1) | (9.3) | |||||||||
| Total | $ | (51.3) | $ | (61.4) | |||||||
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest paid | $ | 15.9 | $ | 10.7 | |||||||
| Income taxes paid, net | $ | 11.2 | $ | 15.9 | |||||||
| Unpaid capital expenditures | $ | 2.7 | $ | 1.4 | |||||||
| (in millions, except share data) | Common Shares Issued at Par Value | Capital Surplus | Retained Earnings | Accumulated Other Comprehensive Loss | Treasury Stock | Total Share-holders’ Equity | Non-controlling Interest | Total | |||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2025 | $ | 72.4 | $ | 1,716.5 | $ | 374.5 | $ | (99.9) | $ | (810.5) | $ | 1,253.0 | $ | (3.1) | $ | 1,249.9 | |||||||||||||||||||||||||||||||
| Noncontrolling interest of acquired entity | — | — | — | — | — | — | 0.9 | 0.9 | |||||||||||||||||||||||||||||||||||||||
| Net income | — | — | 6.4 | — | — | 6.4 | 0.4 | 6.8 | |||||||||||||||||||||||||||||||||||||||
Cash dividends ($0.18 per share) | — | — | (10.3) | — | — | (10.3) | — | (10.3) | |||||||||||||||||||||||||||||||||||||||
| Redeemable noncontrolling interest adjustment | — | (0.2) | — | — | — | (0.2) | 0.2 | — | |||||||||||||||||||||||||||||||||||||||
Exercise of stock options of 2,032 shares | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
| Impact from settlement of stock-based awards, net of shares acquired | — | (11.1) | — | — | 8.2 | (2.9) | — | (2.9) | |||||||||||||||||||||||||||||||||||||||
| Stock-based compensation expense | — | 4.1 | — | — | — | 4.1 | — | 4.1 | |||||||||||||||||||||||||||||||||||||||
| Changes in pension and postretirement plan assets and benefit obligation, net of tax | — | — | — | (0.2) | — | (0.2) | — | (0.2) | |||||||||||||||||||||||||||||||||||||||
| Currency translation adjustment | — | — | — | (10.8) | — | (10.8) | — | (10.8) | |||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2026 | $ | 72.4 | $ | 1,709.3 | $ | 370.6 | $ | (110.9) | $ | (802.3) | $ | 1,239.1 | $ | (1.6) | $ | 1,237.5 | |||||||||||||||||||||||||||||||
| (in millions, except share data) | Common Shares Issued at Par Value | Capital Surplus | Retained Earnings | Accumulated Other Comprehensive Loss | Treasury Stock | Total | |||||||||||||||||||||||||||||
| Balance as of December 31, 2024 | $ | 72.4 | $ | 1,719.9 | $ | 268.4 | $ | (172.6) | $ | (823.2) | $ | 1,064.9 | |||||||||||||||||||||||
| Net income | — | — | 21.7 | — | — | 21.7 | |||||||||||||||||||||||||||||
Cash dividends ($0.17 per share) | — | — | (9.7) | — | — | (9.7) | |||||||||||||||||||||||||||||
Exercise of stock options of 21,879 shares | — | — | — | — | 0.6 | 0.6 | |||||||||||||||||||||||||||||
| Impact from settlement of stock-based awards, net of shares acquired | — | (11.7) | — | — | 7.2 | (4.5) | |||||||||||||||||||||||||||||
| Stock-based compensation expense | — | 2.7 | — | — | — | 2.7 | |||||||||||||||||||||||||||||
| Changes in pension and postretirement plan assets and benefit obligation, net of tax | — | — | — | (0.2) | — | (0.2) | |||||||||||||||||||||||||||||
| Currency translation adjustment | — | — | — | 31.1 | — | 31.1 | |||||||||||||||||||||||||||||
| Balance as of March 31, 2025 | $ | 72.4 | $ | 1,710.9 | $ | 280.4 | $ | (141.7) | $ | (815.4) | $ | 1,106.6 | |||||||||||||||||||||||
Net assets acquired (in millions) | ||||||||
| Cash and cash equivalents | $ | 57.1 | ||||||
| Accounts receivable, net | 62.9 | |||||||
| Inventories, net | 69.9 | |||||||
| Other current assets | 17.8 | |||||||
| Property, plant and equipment | 28.5 | |||||||
| Other non-current assets | 12.0 | |||||||
| Intangible assets | 251.2 | |||||||
| Goodwill | 241.1 | |||||||
| Total assets acquired | $ | 740.5 | ||||||
| Short-term borrowings | $ | 123.5 | ||||||
| Contract liabilities | 47.2 | |||||||
| Other current liabilities | 64.4 | |||||||
| Other liabilities | 87.2 | |||||||
| Total assumed liabilities | $ | 322.3 | ||||||
| Net assets acquired | $ | 418.2 | ||||||
| The following is a summary of the purchase consideration transferred: | ||||||||
| Fair value of previously held equity investment | $ | 135.4 | ||||||
| Cash consideration transferred to acquire control | 281.9 | |||||||
| Fair value of noncontrolling interest | 0.9 | |||||||
| Total consideration of Antares Vision acquisition | $ | 418.2 | ||||||
| Intangible Assets (in millions) | Intangible Fair Value | Weighted Average Life (in years) | |||||||||
| Customer relationships | $ | 150.1 | 20.0 | ||||||||
| Trade names | 17.3 | 9.0 | |||||||||
| Developed technology | 63.5 | 5.0 | |||||||||
| Backlog | 20.3 | 0.9 | |||||||||
| Total acquired intangible assets | $ | 251.2 | |||||||||
Net assets acquired (in millions) | ||||||||
| Accounts receivable, net | $ | 19.9 | ||||||
| Inventories, net | 20.8 | |||||||
| Other current assets | 6.7 | |||||||
| Property, plant and equipment | 27.5 | |||||||
| Other non-current assets | 5.3 | |||||||
| Intangible assets | 184.9 | |||||||
| Goodwill | 188.1 | |||||||
| Total assets acquired | $ | 453.2 | ||||||
| Total current liabilities | $ | 16.3 | ||||||
| Other liabilities | 45.8 | |||||||
| Total assumed liabilities | $ | 62.1 | ||||||
| Net assets acquired | $ | 391.1 | ||||||
| Intangible Assets (in millions) | Intangible Fair Value | Weighted Average Life (in years) | |||||||||
| Customer relationships | $ | 141.5 | 18.2 | ||||||||
| Developed technology | 40.7 | 5.0 | |||||||||
| Backlog | 2.7 | 0.9 | |||||||||
| Total acquired intangible assets | $ | 184.9 | |||||||||
Three Months Ended March 31, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net sales | $ | 429.6 | $ | 401.2 | ||||||||||
| Net income attributable to common shareholders | $ | 0.3 | $ | (5.5) | ||||||||||
(in millions) Three months ended March 31, 2026 | SAT | DTT | Total | |||||||||||||||||
| Net Sales | $ | 192.8 | $ | 194.9 | $ | 387.7 | ||||||||||||||
| Less: | ||||||||||||||||||||
| Cost of operations | 97.5 | 91.2 | ||||||||||||||||||
| Selling and administrative expense | 39.8 | 53.1 | ||||||||||||||||||
| Engineering expense | 8.8 | 7.7 | ||||||||||||||||||
Other segment items (a) | 31.6 | 11.5 | ||||||||||||||||||
| Segment operating profit | $ | 15.1 | $ | 31.4 | $ | 46.5 | ||||||||||||||
| Corporate costs | (24.3) | |||||||||||||||||||
| Operating profit | 22.2 | |||||||||||||||||||
| Interest expense | (17.8) | |||||||||||||||||||
| Equity investment income | 4.7 | |||||||||||||||||||
| Miscellaneous income, net | 0.1 | |||||||||||||||||||
| Income before income taxes | $ | 9.2 | ||||||||||||||||||
(in millions) Three months ended March 31, 2025 | SAT | DTT | Total | |||||||||||||||||
| Net Sales | $ | 127.4 | $ | 202.9 | $ | 330.3 | ||||||||||||||
| Less: | ||||||||||||||||||||
| Cost of operations | 59.1 | 92.3 | ||||||||||||||||||
| Selling and administrative expense | 29.5 | 39.8 | ||||||||||||||||||
| Engineering expense | 9.2 | 9.6 | ||||||||||||||||||
Other segment items (a) | 27.2 | 11.5 | ||||||||||||||||||
| Segment operating profit | $ | 2.4 | $ | 49.7 | $ | 52.1 | ||||||||||||||
| Corporate costs | (14.8) | |||||||||||||||||||
| Operating profit | 37.3 | |||||||||||||||||||
| Interest expense | (11.5) | |||||||||||||||||||
| Equity investment income | 0.1 | |||||||||||||||||||
| Miscellaneous income, net | 2.2 | |||||||||||||||||||
| Income before income taxes | $ | 28.1 | ||||||||||||||||||
(a) | Includes other cost of operations such as manufacturing costs, amortization expenses, shipping and handling costs, and certain overhead expenses, as well as corporate allocations. | ||||
Three months ended March 31, | |||||||||||
| (in millions) | 2026 | 2025 | |||||||||
| Capital expenditures: | |||||||||||
| Security and Authentication Technologies | $ | 9.8 | $ | 6.5 | |||||||
| Detection and Traceability Technologies | 0.5 | 0.8 | |||||||||
| Total | $ | 10.3 | $ | 7.3 | |||||||
Three months ended March 31, | |||||||||||
| (in millions) | 2026 | 2025 | |||||||||
| Depreciation and amortization: | |||||||||||
| Security and Authentication Technologies | $ | 21.2 | $ | 13.9 | |||||||
| Detection and Traceability Technologies | 7.2 | 7.1 | |||||||||
| Corporate | 1.3 | 0.6 | |||||||||
| Total | $ | 29.7 | $ | 21.6 | |||||||
| (in millions) | March 31, 2026 | December 31, 2025 | |||||||||
| Assets: | |||||||||||
| Security and Authentication Technologies | $ | 1,713.2 | $ | 1,734.9 | |||||||
| Detection and Traceability Technologies | 1,878.1 | 1,183.0 | |||||||||
| Corporate and other | 49.1 | 198.5 | |||||||||
| Total | $ | 3,640.4 | $ | 3,116.4 | |||||||
| (in millions) | March 31, 2026 | December 31, 2025 | |||||||||
| Goodwill: | |||||||||||
| Security and Authentication Technologies | $ | 536.3 | $ | 539.8 | |||||||
| Detection and Traceability Technologies | 861.9 | 624.2 | |||||||||
| Total | $ | 1,398.2 | $ | 1,164.0 | |||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Security and Authentication Technologies | ||||||||||||||
| Banknotes and Security Products | $ | 140.4 | $ | 93.4 | ||||||||||
| Authentication Products and Solutions | 52.4 | 34.0 | ||||||||||||
| Total Security and Authentication Technologies | $ | 192.8 | $ | 127.4 | ||||||||||
| Detection and Traceability Technologies | ||||||||||||||
| Detection and Inspection Products and Solutions | $ | 160.1 | $ | 169.9 | ||||||||||
| Services | 34.8 | 33.0 | ||||||||||||
| Total Detection and Traceability Technologies | $ | 194.9 | $ | 202.9 | ||||||||||
| Net sales | $ | 387.7 | $ | 330.3 | ||||||||||
| (in millions) | March 31, 2026 | December 31, 2025 | |||||||||
| Contract assets | $ | 59.4 | $ | 56.1 | |||||||
| Current contract liabilities | $ | 169.2 | $ | 87.3 | |||||||
| Long-term contract liabilities | $ | 9.6 | $ | 17.0 | |||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| (in millions, except per share data) | 2026 | 2025 | |||||||||
| Net income attributable to common shareholders | $ | 6.4 | $ | 21.7 | |||||||
| Average basic shares outstanding | 57.5 | 57.3 | |||||||||
| Effect of dilutive stock-based awards | 0.5 | 0.6 | |||||||||
| Average diluted shares outstanding | 58.0 | 57.9 | |||||||||
| Earnings per basic share | $ | 0.11 | $ | 0.38 | |||||||
| Earnings per diluted share | $ | 0.11 | $ | 0.38 | |||||||
| (in millions) | Pension and Postretirement Benefits (a) | Currency Translation Adjustment | Total | |||||||||||||||||
| Balance as of December 31, 2025 | $ | 1.2 | $ | (101.1) | $ | (99.9) | ||||||||||||||
| Other comprehensive loss before reclassifications | — | (10.8) | (10.8) | |||||||||||||||||
| Amounts reclassified from accumulated other comprehensive income | (0.2) | — | (0.2) | |||||||||||||||||
| Net period other comprehensive loss | (0.2) | (10.8) | (11.0) | |||||||||||||||||
| Balance as of March 31, 2026 | $ | 1.0 | $ | (111.9) | $ | (110.9) | ||||||||||||||
(a) Net of tax detriment of $1.0 million and $1.1 million as of March 31, 2026 and December 31, 2025, respectively. | ||
| Pension | Postretirement | ||||||||||||||||||||||
| (in millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Service cost | $ | 0.4 | $ | 0.5 | $ | — | $ | — | |||||||||||||||
| Interest cost | 0.5 | 0.4 | 0.1 | 0.1 | |||||||||||||||||||
| Expected return on plan assets | (0.7) | (0.6) | — | — | |||||||||||||||||||
| Amortization of prior service cost | (0.1) | (0.2) | — | — | |||||||||||||||||||
| Amortization of net gain | — | — | (0.2) | (0.1) | |||||||||||||||||||
| Net periodic expense (benefit) | $ | 0.1 | $ | 0.1 | $ | (0.1) | $ | — | |||||||||||||||
| (in millions) | Pension | Postretirement | |||||||||
Expected contributions in 2026 | $ | 1.2 | $ | 1.2 | |||||||
Amounts contributed during the three months ended March 31, 2026 | $ | 0.6 | $ | 0.9 | |||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Effective Tax Rate | 25.8% | 22.7% | |||||||||
| (in millions) | SAT | DTT | Total | ||||||||
Balance as of December 31, 2025 | $ | 539.8 | $ | 624.2 | $ | 1,164.0 | |||||
| Additions (see Note 2) | — | 241.1 | 241.1 | ||||||||
| Currency translation and other | (3.5) | (3.4) | (6.9) | ||||||||
Balance as of March 31, 2026 | $ | 536.3 | $ | 861.9 | $ | 1,398.2 | |||||
| (in millions) | Three Months Ended March 31, 2026 | Year Ended December 31, 2025 | |||||||||
| Balance at beginning of period, net of accumulated amortization | $ | 557.2 | $ | 419.3 | |||||||
| Additions (see Note 2) | 251.7 | 191.1 | |||||||||
| Amortization expense | (16.3) | (59.5) | |||||||||
| Currency translation and other | (3.3) | 6.3 | |||||||||
Balance at end of period, net of accumulated amortization1 | $ | 789.3 | $ | 557.2 | |||||||
1 Includes $45.5 million intangibles with indefinite useful lives. | |||||||||||
| Weighted Average Amortization Period of Finite Lived Assets (in years) | March 31, 2026 | December 31, 2025 | |||||||||||||||||||||||||||||||||||||||
| (in millions) | Gross Asset | Accumulated Amortization | Net | Gross Asset | Accumulated Amortization | Net | |||||||||||||||||||||||||||||||||||
| Intellectual property rights | 8.5 | $ | 83.2 | $ | 18.4 | $ | 18.5 | $ | 64.7 | $ | 66.0 | $ | 18.4 | $ | 18.4 | $ | 47.6 | ||||||||||||||||||||||||
| Customer relationships and backlog | 19.1 | 933.6 | 339.2 | 349.2 | 584.4 | 767.9 | 339.2 | 339.2 | 428.7 | ||||||||||||||||||||||||||||||||
| Developed Technology | 6.0 | 176.3 | 42.2 | 45.1 | 131.2 | 113.2 | 42.2 | 42.2 | 71.0 | ||||||||||||||||||||||||||||||||
| Other | 12.2 | 74.5 | 65.1 | 65.5 | 9.0 | 75.0 | 65.1 | 65.1 | 9.9 | ||||||||||||||||||||||||||||||||
| Total | 18.4 | $ | 1,267.6 | $ | 478.3 | $ | 789.3 | $ | 1,022.1 | $ | 464.9 | $ | 557.2 | ||||||||||||||||||||||||||||
| (in millions) | |||||
| Remainder of 2026 | $ | 81.6 | |||
| 2027 | $ | 86.8 | |||
| 2028 | $ | 77.9 | |||
| 2029 | $ | 75.5 | |||
| 2030 | $ | 53.9 | |||
| 2031 and after | $ | 368.1 | |||
| (in millions) | March 31, 2026 | December 31, 2025 | |||||||||
| Contract liabilities | $ | 169.2 | $ | 87.3 | |||||||
| Employee related expenses | 67.8 | 58.5 | |||||||||
| Current lease liabilities | 13.9 | 14.6 | |||||||||
| Accrued interest | 7.9 | 7.6 | |||||||||
| Warranty | 12.9 | 10.9 | |||||||||
Share deposit liabilities1 | — | 14.4 | |||||||||
| Other | 86.4 | 79.7 | |||||||||
| Total | $ | 358.1 | $ | 273.0 | |||||||
| (in millions) | March 31, 2026 | December 31, 2025 | ||||||||||||
| Debt assumed in connection with Antares Vision acquisition (see Note 2) | $ | 123.5 | $ | — | ||||||||||
| Term Loan A | — | 9.1 | ||||||||||||
| Revolving Facility | 126.0 | 126.0 | ||||||||||||
Total short-term borrowings (a) | $ | 249.5 | $ | 135.1 | ||||||||||
| Term Loan A | $ | 242.0 | $ | 351.4 | ||||||||||
| Term Loan B | 484.4 | 120.7 | ||||||||||||
6.55% notes due November 2036 | 198.8 | 198.8 | ||||||||||||
4.20% notes due March 2048 | 346.9 | 346.9 | ||||||||||||
| Other deferred financing costs associated with credit facilities | (12.7) | (13.4) | ||||||||||||
Total long-term debt (a) | $ | 1,259.4 | $ | 1,004.4 | ||||||||||
(a) Debt discounts and debt issuance costs totaled $30.9 million and $30.7 million as of March 31, 2026, and December 31, 2025, respectively, and have been netted against the aggregate principal amounts of the related debt in the components of the debt table above, where applicable. | ||||||||||||||
March 31, 2026 (in millions) | Location on Consolidated Balance Sheets | Active Markets for Identical Assets and Liabilities Level 1 | Other Observable Inputs Level 2 | Unobservable Inputs Level 3 | Total Fair Value | |||||||||||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||
Foreign exchange contract not designated as hedging instrument1 | Accrued Liabilities | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||
| Long-term debt | Long-term debt | $ | — | $ | 415.0 | $ | — | $ | 415.0 | |||||||||||||||||||||||
Performance-based restricted share units | Other Liabilities | $ | 1.0 | $ | — | $ | — | $ | 1.0 | |||||||||||||||||||||||
| Contingent Liability | Other Liabilities | $ | — | $ | — | $ | 1.3 | $ | 1.3 | |||||||||||||||||||||||
December 31, 2025 (in millions) | Location on Consolidated Balance Sheets | Active Markets for Identical Assets and Liabilities Level 1 | Other Observable Inputs Level 2 | Unobservable Inputs Level 3 | Total Fair Value | |||||||||||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||
Foreign exchange contract not designated as hedging instrument1 | Accrued Liabilities | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||
| Long-term debt | Long-term debt | $ | — | $ | 440.3 | $ | — | $ | 440.3 | |||||||||||||||||||||||
Performance-based restricted share units | Other Liabilities | $ | 1.0 | $ | — | $ | — | $ | 1.0 | |||||||||||||||||||||||
| Contingent Liability | Other Liabilities | $ | — | $ | — | $ | 1.3 | $ | 1.3 | |||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||||||||
| Security and Authentication Technologies | $ | 2.2 | $ | — | ||||||||||||||||
| Detection and Traceability Technologies | 0.9 | — | ||||||||||||||||||
| Total restructuring charges | $ | 3.1 | $ | — | ||||||||||||||||
| (in millions) | 2025 Restructuring | 2024 Restructuring | Total | |||||||||||||||||
| Severance: | ||||||||||||||||||||
Balance as of December 31, 2025 (a) | $ | 7.2 | $ | 0.8 | $ | 8.0 | ||||||||||||||
Expense (b) | 1.9 | 0.3 | 2.2 | |||||||||||||||||
| Utilization | (4.1) | (0.8) | (4.9) | |||||||||||||||||
Balance as of March 31, 2026 (a) | $ | 5.0 | $ | 0.3 | $ | 5.3 | ||||||||||||||
| (a) | Included within Accrued Liabilities in the Unaudited Condensed Consolidated Balance Sheets. | ||||
| (b) | Included within “Restructuring charges” in the Unaudited Condensed Consolidated Statements of Operations. | ||||
| Three Months Ended March 31, | Favorable/(Unfavorable) Change | ||||||||||||||||||||||
| (in millions) | 2026 | 2025 | $ | % | |||||||||||||||||||
| Net sales | $ | 387.7 | $ | 330.3 | $ | 57.4 | 17.4 | % | |||||||||||||||
| Cost of sales | $ | 231.8 | $ | 190.1 | $ | (41.7) | (21.9) | % | |||||||||||||||
| as a percentage of sales | 59.8 | % | 57.6 | % | |||||||||||||||||||
| Selling, general and administrative | $ | 130.6 | $ | 102.9 | $ | (27.7) | (26.9) | % | |||||||||||||||
| as a percentage of sales | 33.7 | % | 31.2 | % | |||||||||||||||||||
| Restructuring charges | 3.1 | — | (3.1) | NM | |||||||||||||||||||
| Operating profit | $ | 22.2 | $ | 37.3 | $ | (15.1) | (40.5) | % | |||||||||||||||
| Operating margin | 5.7 | % | 11.3 | % | |||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||
| Interest expense | (17.8) | (11.5) | (6.3) | (54.8) | % | ||||||||||||||||||
| Equity investment income | 4.7 | 0.1 | 4.6 | NM | |||||||||||||||||||
| Miscellaneous income, net | 0.1 | 2.2 | (2.1) | NM | |||||||||||||||||||
| Total other expense, net | (13.0) | (9.2) | (3.8) | (41.3) | % | ||||||||||||||||||
| Income before income taxes | 9.2 | 28.1 | (18.9) | (67.3) | % | ||||||||||||||||||
| Provision for income taxes | 2.4 | 6.4 | 4.0 | 62.5 | % | ||||||||||||||||||
| Net income before allocation to noncontrolling interest | $ | 6.8 | $ | 21.7 | $ | (14.9) | (68.7) | % | |||||||||||||||
| Less: noncontrolling interest in subsidiaries’ earnings | $ | 0.4 | $ | — | $ | 0.4 | NM | ||||||||||||||||
| Net income attributable to common shareholders | $ | 6.4 | $ | 21.7 | $ | (15.3) | (70.5) | % | |||||||||||||||
| Three Months Ended March 31, | Favorable/(Unfavorable) Change | ||||||||||||||||||||||
| (in millions) | 2026 | 2025 | $ | % | |||||||||||||||||||
| Net sales by product line: | |||||||||||||||||||||||
| Banknotes and Security Products | $ | 140.4 | $ | 93.4 | $ | 47.0 | 50.3 | % | |||||||||||||||
| Authentication Products and Solutions | 52.4 | 34.0 | 18.4 | NM | |||||||||||||||||||
| Total net sales | $ | 192.8 | $ | 127.4 | $ | 65.4 | 51.3 | % | |||||||||||||||
| Cost of sales | $ | 129.1 | $ | 86.3 | $ | (42.8) | (49.6) | % | |||||||||||||||
| as a percentage of sales | 67.0 | % | 67.7 | % | |||||||||||||||||||
| Selling, general and administrative | $ | 46.4 | $ | 38.7 | $ | (7.7) | (19.9) | % | |||||||||||||||
| as a percentage of sales | 24.1 | % | 30.4 | % | |||||||||||||||||||
| Restructuring charges | $ | 2.2 | $ | — | $ | (2.2) | NM | ||||||||||||||||
| Operating profit | $ | 15.1 | $ | 2.4 | $ | 12.7 | NM | ||||||||||||||||
| Operating margin | 7.8 | % | 1.9 | % | |||||||||||||||||||
| Three Months Ended March 31, | Favorable/(Unfavorable) Change | ||||||||||||||||||||||
| (in millions) | 2026 | 2025 | $ | % | |||||||||||||||||||
| Net sales by product line: | |||||||||||||||||||||||
| Detection and Inspection Products and Solutions | $ | 160.1 | $ | 169.9 | $ | (9.8) | (5.8) | % | |||||||||||||||
| Services | 34.8 | 33.0 | 1.8 | 5.5 | % | ||||||||||||||||||
| Total net sales | $ | 194.9 | $ | 202.9 | $ | (8.0) | (4.0) | % | |||||||||||||||
| Cost of sales | $ | 102.7 | $ | 103.8 | $ | 1.1 | 1.1 | % | |||||||||||||||
| as a percentage of sales | 52.7 | % | 51.2 | % | |||||||||||||||||||
| Selling, general and administrative | $ | 59.9 | $ | 49.4 | $ | (10.5) | (21.3) | % | |||||||||||||||
| as a percentage of sales | 30.7 | % | 24.3 | % | |||||||||||||||||||
| Restructuring charges | $ | 0.9 | $ | — | $ | (0.9) | NM | ||||||||||||||||
| Operating profit | $ | 31.4 | $ | 49.7 | $ | (18.3) | (36.8) | % | |||||||||||||||
| Operating margin | 16.1 | % | 24.5 | % | |||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net cash (used for) provided by: | ||||||||||||||
| Operating activities | $ | (14.0) | $ | (19.1) | ||||||||||
| Investing activities | (231.2) | (13.6) | ||||||||||||
| Financing activities | 239.8 | 38.0 | ||||||||||||
| Effect of exchange rates on cash, cash equivalents and restricted cash | (1.8) | 6.7 | ||||||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash | $ | (7.2) | $ | 12.0 | ||||||||||
| Exhibit 31.1* | |||||||||||
| Exhibit 31.2* | |||||||||||
| Exhibit 32.1** | |||||||||||
| Exhibit 32.2** | |||||||||||
| 101.INS | XBRL Instance Document - the instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema (filed herewith) | ||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase (filed herewith) | ||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase (filed herewith) | ||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase (filed herewith) | ||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase (filed herewith) | ||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||||||||
| CRANE NXT, CO. | ||||||||
| REGISTRANT | ||||||||
| Date | ||||||||
| May 6, 2026 | By | /s/ Aaron Saak | ||||||
| Aaron Saak | ||||||||
| President and Chief Executive Officer | ||||||||
| Date | By | /s/ Christina Cristiano | ||||||
| May 6, 2026 | Christina Cristiano | |||||||
| Senior Vice President and Chief Financial Officer | ||||||||
| By /s/ Aaron Saak | ||
| Aaron Saak | ||
| President and Chief Executive Officer | ||
| May 6, 2026 | ||
| By /s/ Christina Cristiano | ||
| Christina Cristiano | ||
| Principal Financial Officer | ||
| May 6, 2026 | ||
| By /s/ Aaron Saak | ||
| Aaron Saak | ||
| President and Chief Executive Officer | ||
| May 6, 2026 | ||
| By /s/ Christina Cristiano | ||
| Christina Cristiano | ||
| Principal Financial Officer | ||
| May 6, 2026 | ||